{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:35:25Z","timestamp":1787070925713,"version":"build-2736575974"},"reference-count":79,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:00:00Z","timestamp":1698105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Cardiovascular disease, including ischemic heart disease, is the leading cause of death worldwide, and percutaneous coronary interventions (PCIs) have been demonstrated to improve the prognosis of these patients on top of optimal medical therapy. PCIs have evolved from plain old balloon angioplasty to coronary stent implantation at the end of the last century. There has been a constant technical and scientific improvement in stent technology from bare metal stents to the era of drug-eluting stents (DESs) to overcome clinical challenges such as target lesion failure related to in-stent restenosis or stent thrombosis. A better understanding of the underlying mechanisms of these adverse events has led DESs to evolve from first-generation DESs to thinner and ultrathin third-generation DESs with improved polymer biocompatibility that seems to have reached a peak in efficiency. This review aims to provide a brief historical overview of the evolution of coronary DES platforms and an update on clinical studies and major characteristics of the most currently used DESs.<\/jats:p>","DOI":"10.3390\/jcm12216711","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T11:39:04Z","timestamp":1698147544000},"page":"6711","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5699-7557","authenticated-orcid":false,"given":"Pierre","family":"Brami","sequence":"first","affiliation":[{"name":"Department of Cardiology, Cochin Hospital, H\u00f4pitaux Universitaire Paris Centre, Assistance Publique des H\u00f4pitaux de Paris, 75014 Paris, France"},{"name":"D\u00e9partement Sant\u00e9, Universit\u00e9 Paris-Cit\u00e9, 75006 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6651-6868","authenticated-orcid":false,"given":"Quentin","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cochin Hospital, H\u00f4pitaux Universitaire Paris Centre, Assistance Publique des H\u00f4pitaux de Paris, 75014 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7391-1521","authenticated-orcid":false,"given":"Vincent","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cochin Hospital, H\u00f4pitaux Universitaire Paris Centre, Assistance Publique des H\u00f4pitaux de Paris, 75014 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0774-8356","authenticated-orcid":false,"given":"Gabriel","family":"Seret","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cochin Hospital, H\u00f4pitaux Universitaire Paris Centre, Assistance Publique des H\u00f4pitaux de Paris, 75014 Paris, France"},{"name":"D\u00e9partement Sant\u00e9, Universit\u00e9 Paris-Cit\u00e9, 75006 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Varenne","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cochin Hospital, H\u00f4pitaux Universitaire Paris Centre, Assistance Publique des H\u00f4pitaux de Paris, 75014 Paris, France"},{"name":"D\u00e9partement Sant\u00e9, Universit\u00e9 Paris-Cit\u00e9, 75006 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8025-9589","authenticated-orcid":false,"given":"Fabien","family":"Picard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cochin Hospital, H\u00f4pitaux Universitaire Paris Centre, Assistance Publique des H\u00f4pitaux de Paris, 75014 Paris, France"},{"name":"D\u00e9partement Sant\u00e9, Universit\u00e9 Paris-Cit\u00e9, 75006 Paris, France"},{"name":"INSERM U970, Paris Cardiovascular Research Center (PARCC), European Georges Pompidou Hospital, 75015 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3109\/00016925309136722","article-title":"Catheter replacement of the needle in percutaneous arteriography: A new technique","volume":"39","author":"Seldinger","year":"1953","journal-title":"Acta Radiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0031-3955(16)30724-6","article-title":"Cine-Cardio-Angiography","volume":"5","year":"1958","journal-title":"Pediatr. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM197907123010201","article-title":"Nonoperative dilatation of coronary-artery stenosis: Percutaneous transluminal coronary angioplasty","volume":"301","author":"Senning","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"ref_4","first-page":"119","article-title":"The sliding rail system (monorail): Description of a new technique for intravascular instrumentation and its application to coronary angioplasty","volume":"76","author":"Bonzel","year":"1987","journal-title":"Z. Kardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.cjca.2022.06.019","article-title":"The Ongoing Saga of the Evolution of Percutaneous Coronary Intervention: From Balloon Angioplasty to Recent Innovations to Future Prospects","volume":"38","author":"Picard","year":"2022","journal-title":"Can. J. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/14779072.2018.1435274","article-title":"The evolution of coronary stents","volume":"16","author":"McKavanagh","year":"2018","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease","volume":"331","author":"Serruys","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease","volume":"331","author":"Fischman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery Stents","volume":"334","author":"Neumann","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery","volume":"349","author":"Moses","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.294.10.1215","article-title":"Comparison of a Polymer-Based Paclitaxel-Eluting Stent with a Bare Metal Stent in Patients with Complex Coronary Artery Disease A Randomized Controlled Trial","volume":"294","author":"Stone","year":"2005","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jama.295.8.895","article-title":"Sirolimus- vs Paclitaxel-Eluting Stents in De Novo Coronary Artery Lesions The REALITY Trial: A Randomized Controlled Trial","volume":"295","author":"Morice","year":"2006","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.293.2.165","article-title":"Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients with Coronary In-Stent Restenosis: A Randomized Controlled Trial","volume":"293","author":"Kastrati","year":"2005","journal-title":"JAMA"},{"key":"ref_15","first-page":"1519","article-title":"Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy","volume":"364","author":"McFadden","year":"2004","journal-title":"Cardiology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jcin.2011.03.005","article-title":"Long-Term Safety and Efficacy of Paclitaxel-Eluting Stents","volume":"4","author":"Stone","year":"2011","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of Drug-Eluting Stents in Humans","volume":"48","author":"Joner","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1161\/01.CIR.103.23.2816","article-title":"Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial","volume":"103","author":"Kastrati","year":"2001","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0735-1097(03)00119-0","article-title":"Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial","volume":"41","author":"Pache","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e008024","DOI":"10.1161\/CIRCINTERVENTIONS.119.008024","article-title":"Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients with Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial","volume":"12","author":"Iglesias","year":"2019","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.amjcard.2018.07.040","article-title":"Meta-Analysis of the Impact of Strut Thickness on Outcomes in Patients with Drug-Eluting Stents in a Coronary Artery","volume":"122","author":"Iantorno","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/MDER.S22043","article-title":"Everolimus-eluting stents: Update on current clinical studies","volume":"91","author":"Joshi","year":"2011","journal-title":"Med. Devices Evid. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.addr.2006.01.021","article-title":"Zotarolimus (ABT-578) eluting stents","volume":"58","author":"Burke","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.amjcard.2007.08.020","article-title":"The Significance of Preclinical Evaluation of Sirolimus-, Paclitaxel-, and Zotarolimus-Eluting Stents","volume":"100","author":"Nakazawa","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10554-011-9849-7","article-title":"Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: Comparison with sirolimus-eluting stent using optical coherence tomography","volume":"28","author":"Choi","year":"2012","journal-title":"Int. J. Cardiovasc. Imaging."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jcin.2010.12.014","article-title":"Late-Term Clinical Outcomes with Zotarolimus- and Sirolimus-Eluting Stents","volume":"4","author":"Kandzari","year":"2011","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4244\/EIJV8I9A161","article-title":"Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: The SPIRIT II trial","volume":"8","author":"Onuma","year":"2013","journal-title":"EuroIntervention"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.jcin.2017.06.070","article-title":"Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease","volume":"10","author":"Kelly","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2014.12.046","article-title":"Short- Versus Long-Term Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation","volume":"65","author":"Palmerini","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.repc.2020.12.004","article-title":"The third generation of drug-eluting stents: Reassuring data while we wait for the next one","volume":"40","year":"2021","journal-title":"Rev. Port. Cardiol."},{"key":"ref_31","first-page":"286","article-title":"A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial","volume":"2","author":"Serruys","year":"2006","journal-title":"EuroIntervention J. Eur. Collab. Work Group Interv. Cardiol. Eur. Soc. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/CIRCULATIONAHA.111.063644","article-title":"Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated with Percutaneous Coronary Intervention: The Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV)","volume":"125","author":"Thayssen","year":"2012","journal-title":"Circulation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.4244\/EIJ-D-18-01214","article-title":"BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: Primary outcome target vessel failure at 12 months","volume":"15","author":"Saito","year":"2019","journal-title":"EuroIntervention"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.17925\/HI.2021.15.2.65","article-title":"XIENCE Implantation Followed By Short Dual Antiplatelet Therapy: \u2018The New Normal\u2019?","volume":"15","author":"Kikkert","year":"2021","journal-title":"Heart Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(13)62037-1","article-title":"Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): A randomised, single-blind, multicentre, non-inferiority trial","volume":"383","author":"Sen","year":"2014","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jacc.2012.01.008","article-title":"A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients","volume":"59","author":"Basalus","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(14)61794-3","article-title":"Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): A randomised non-inferiority trial","volume":"385","author":"Raungaard","year":"2015","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcin.2016.11.004","article-title":"5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent","volume":"10","author":"Yeh","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ccd.27322","article-title":"Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial","volume":"92","author":"Price","year":"2018","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJMoa1910021","article-title":"Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk","volume":"382","author":"Windecker","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0140-6736(16)31920-1","article-title":"Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): A three-arm, randomised, non-inferiority trial","volume":"388","author":"Kok","year":"2016","journal-title":"Lancet"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2011.12.016","article-title":"Primary Endpoint Results of the EVOLVE Trial","volume":"59","author":"Meredith","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e002372","DOI":"10.1161\/CIRCINTERVENTIONS.114.002372","article-title":"Efficacy and Safety of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent: The EVOLVE II Randomized Trial","volume":"8","author":"Kereiakes","year":"2015","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0735-1097(19)31636-5","article-title":"Final 5-year outcomes of the evolve ii trial: A prospective randomized investigation of a novel bioabsorbable polymer-coated, everolimus-eluting synergy stent","volume":"73","author":"Kereiakes","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e010144","DOI":"10.1161\/CIRCINTERVENTIONS.120.010144","article-title":"Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated with a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent","volume":"14","author":"Kirtane","year":"2021","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ccd.27030","article-title":"Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography Angioplasty Registry (SCAAR): Everolimus Bioabsorbable Polymer Stent in, S.C.A.A.R","volume":"90","author":"Sarno","year":"2017","journal-title":"Catheter Cardiovasc. Interv."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0140-6736(14)61038-2","article-title":"Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): A randomised, single-blind, non-inferiority trial","volume":"384","author":"Pilgrim","year":"2014","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(17)32249-3","article-title":"Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): A randomised trial","volume":"390","author":"Kandzari","year":"2017","journal-title":"Lancet"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jcin.2022.07.027","article-title":"Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents","volume":"15","author":"Kandzari","year":"2022","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(19)31877-X","article-title":"Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): A single-blind, prospective, randomised superiority trial","volume":"394","author":"Iglesias","year":"2019","journal-title":"Lancet"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcin.2020.12.011","article-title":"Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI","volume":"14","author":"Pilgrim","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0140-6736(18)32001-4","article-title":"Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt\u2013chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): An international, single-blind, randomised non-inferiority trial","volume":"392","author":"Zocca","year":"2018","journal-title":"Lancet"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(08)61244-1","article-title":"Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): A randomised non-inferiority trial","volume":"372","author":"Windecker","year":"2008","journal-title":"Lancet"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2013.04.011","article-title":"Improved Safety and Reduction in Stent Thrombosis Associated with Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients with Coronary Artery Disease","volume":"6","author":"Serruys","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jcin.2018.12.036","article-title":"Everolimus-Eluting Versus Biolimus-Eluting Stents with Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention","volume":"12","author":"Maeng","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.4244\/EIJ-D-20-00185","article-title":"BioMatrix versus Orsiro biodegradable polymer stents in all-comer patients with coronary artery disease: The multicentre, randomised BIODEGRADE trial","volume":"16","author":"Yoon","year":"2021","journal-title":"EuroIntervention"},{"key":"ref_57","first-page":"100472","article-title":"First clinical evidence characterizing safety and efficacy of the new CoCr Biolimus-A9 eluting stent: The Biomatrix AlphaTM registry","volume":"26","author":"Menown","year":"2020","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/eurheartj\/ehu210","article-title":"A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: The CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial","volume":"35","author":"Saito","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ccd.30042","article-title":"Complete revascularization optimizes patient outcomes in multivessel coronary artery disease: Data from the e-Ultimaster registry","volume":"99","author":"Williams","year":"2022","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.111.026732","article-title":"Polymer-Free Sirolimus- and Probucol-Eluting Versus New Generation Zotarolimus-Eluting Stents in Coronary Artery Disease: The Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting Versus Zotarolimus-Eluting Stents (ISAR-TEST 5) Trial","volume":"124","author":"Massberg","year":"2011","journal-title":"Circulation"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jacc.2020.05.026","article-title":"10-Year Outcomes From a Randomized Trial of Polymer-Free Versus Durable Polymer Drug-Eluting Coronary Stents","volume":"76","author":"Kufner","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_63","first-page":"8053168","article-title":"Efficacy and Safety of Polymer-Free Ultrathin Strut Sirolimus-Probucol Coated Drug-Eluting Stents for Chronic Total Occlusions: Insights from the Coroflex\u00ae ISAR 2000 Worldwide Registry","volume":"2018","author":"Krackhardt","year":"2018","journal-title":"Cardiol. Res. Pract."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk","volume":"373","author":"Urban","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1161\/CIRCULATIONAHA.119.040241","article-title":"Randomized Comparison of the Polymer-Free Biolimus-Coated Biofreedom Stent with the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention: The SORT OUT IX Trial","volume":"141","author":"Jensen","year":"2020","journal-title":"Circulation"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4244\/EIJ-D-20-01162","article-title":"Thin- versus thick-strut polymer-free biolimus-eluting stents: The Biofreedom QCA randomised trial","volume":"17","author":"Tilsted","year":"2021","journal-title":"EuroIntervention"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"F15","DOI":"10.4244\/EIJV5IFA3","article-title":"Design principles and performance of bioresorbable polymeric vascular scaffolds","volume":"5","author":"Oberhauser","year":"2009","journal-title":"EuroIntervention"},{"key":"ref_68","first-page":"70","article-title":"Biodegradable stents: They do their job and disappear","volume":"18","author":"Waksman","year":"2006","journal-title":"J. Invasive Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5339\/gcsp.2014.55","article-title":"Bioresorbable scaffolds for percutaneous coronary interventions","volume":"2014","author":"Gogas","year":"2014","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Je\u017cewski, M.P., Kubisa, M.J., Eyileten, C., De Rosa, S., Christ, G., Lesiak, M., Indolfi, C., Toma, A., Siller-Matula, J.M., and Postu\u0142a, M. (2019). Bioresorbable Vascular Scaffolds\u2014Dead End or Still a Rough Diamond?. J. Clin. Med., 8.","DOI":"10.3390\/jcm8122167"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCINTERVENTIONS.113.000990","article-title":"Long-Term Safety of an Everolimus-Eluting Bioresorbable Vascular Scaffold and the Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model","volume":"7","author":"Otsuka","year":"2014","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijcard.2017.12.053","article-title":"In vivo serial invasive imaging of the second-generation drug-eluting absorbable metal scaffold (Magmaris\u2014DREAMS 2G) in de novo coronary lesions: Insights from the BIOSOLVE-II First-In-Man Trial","volume":"255","author":"Haude","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","article-title":"Bioresorbable Scaffolds versus Metallic Stents in Routine, P.C.I","volume":"376","author":"Wykrzykowska","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2017.10.010","article-title":"3-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Coronary Scaffolds","volume":"70","author":"Kereiakes","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.acvd.2018.04.001","article-title":"Bioresorbable vascular scaffolds: Time to absorb past lessons or fade away?","volume":"111","author":"Varenne","year":"2018","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Cherian, A.M., Nair, S.V., Maniyal, V., and Menon, D. (2021). Surface engineering at the nanoscale: A way forward to improve coronary stent efficacy. APL Bioeng., 5.","DOI":"10.1063\/5.0037298"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e10116","DOI":"10.1002\/mds3.10116","article-title":"Perspectives on smart stents with sensors: From conventional permanent to novel bioabsorbable smart stent technologies","volume":"3","author":"Vishnu","year":"2020","journal-title":"Med. Devices Sens."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"163","DOI":"10.14797\/mdcj-12-3-163","article-title":"Enhancing Stent Effectiveness with Nanofeatures","volume":"12","author":"Bassous","year":"2016","journal-title":"Methodist DeBakey Cardiovasc. J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.15420\/ecr.2018:8:2","article-title":"Cardiology Service, Interventional Cardiology Unit, University Hospital Marques de Valdecilla, Santander, Spain. The Newest Generation of Drug-eluting Stents and Beyond","volume":"13","author":"Lee","year":"2018","journal-title":"Eur. Cardiol. Rev."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/21\/6711\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:10:47Z","timestamp":1760130647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/21\/6711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,24]]},"references-count":79,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["jcm12216711"],"URL":"https:\/\/doi.org\/10.3390\/jcm12216711","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,24]]}}}